IRIS UniCatt

De Candia, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.094
AS - Asia 2.633
EU - Europa 2.441
SA - Sud America 510
AF - Africa 78
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.017
SG - Singapore 1.266
CN - Cina 553
DE - Germania 449
BR - Brasile 434
IT - Italia 395
PL - Polonia 382
SE - Svezia 381
VN - Vietnam 246
FR - Francia 176
UA - Ucraina 142
IE - Irlanda 137
GB - Regno Unito 111
IN - India 102
ID - Indonesia 82
FI - Finlandia 79
JP - Giappone 79
HK - Hong Kong 57
RU - Federazione Russa 51
CA - Canada 34
MX - Messico 33
AR - Argentina 32
IQ - Iraq 32
NL - Olanda 32
TR - Turchia 31
BD - Bangladesh 26
AT - Austria 23
PK - Pakistan 21
IR - Iran 20
ZA - Sudafrica 20
BE - Belgio 19
KR - Corea 17
AU - Australia 16
EG - Egitto 16
EC - Ecuador 15
JO - Giordania 14
ES - Italia 12
HU - Ungheria 12
MA - Marocco 12
UZ - Uzbekistan 12
MY - Malesia 9
RO - Romania 9
IL - Israele 8
PH - Filippine 8
SA - Arabia Saudita 8
VE - Venezuela 8
CH - Svizzera 7
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BH - Bahrain 5
CL - Cile 5
LB - Libano 5
PY - Paraguay 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MK - Macedonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
MN - Mongolia 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
AM - Armenia 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
Totale 8.772
Salva come PNG Salva come JPEG
Città #
Singapore 754
Warsaw 374
Ashburn 371
Chandler 333
San Jose 278
Dublin 131
Beijing 115
Fairfield 106
San Mateo 90
Wilmington 85
Ho Chi Minh City 82
Los Angeles 82
Rome 77
Jakarta 72
Jacksonville 69
New York 67
Tokyo 67
Hanoi 66
Lauterbourg 66
Council Bluffs 65
Woodbridge 62
Hefei 60
Ann Arbor 59
Nanjing 59
Munich 56
Hong Kong 52
Seattle 50
Boston 48
Houston 48
Marseille 42
Frankfurt am Main 39
Chicago 38
Milan 38
Moscow 36
Princeton 36
São Paulo 36
Boardman 34
Dearborn 33
The Dalles 32
Buffalo 29
Cambridge 28
Cattolica 28
Redwood City 28
Dallas 27
Helsinki 25
Hyderabad 23
London 22
Lawrence 20
Nuremberg 20
Nanchang 18
Rio de Janeiro 17
Brussels 16
Seoul 16
Santa Clara 15
Da Nang 14
Turku 14
Augusta 13
Hangzhou 13
Redmond 13
Shanghai 13
Amman 12
Andover 12
Denver 12
Guangzhou 12
Kent 12
Lappeenranta 12
Nürnberg 12
Pune 12
St Louis 12
Chennai 11
Curitiba 11
Izmir 11
Norwalk 11
Baghdad 10
Bremen 10
Budapest 10
Guarulhos 10
Montreal 10
Mountain View 10
San Diego 10
Tashkent 10
Vienna 10
Zhengzhou 10
Brasília 9
Johannesburg 9
Paris 9
Verona 9
Washington 9
Atlanta 8
Bari 8
Belo Horizonte 8
Bologna 8
Brooklyn 8
Hebei 8
Naples 8
Salvador 8
San Francisco 8
Düsseldorf 7
Guayaquil 7
Haiphong 7
Totale 5.010
Salva come PNG Salva come JPEG
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 340
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 277
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 213
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 212
Data on the application of early coagulation support protocol in the management of major trauma patients 195
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 178
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 172
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 170
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 170
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 164
Effect of fibrinogen concentration on the velocity of platelet aggregation. 159
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 151
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 150
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 147
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 147
Functional role of protease activated receptors in vascular biology 143
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 139
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 138
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 137
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 136
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 135
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 132
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 130
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 129
Hemophilia A and von Willebrand deficiency: therapeutic implications 129
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 128
Mechanisms of platelet activation by thrombin: a short history 126
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 125
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 122
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 121
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 119
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 117
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 116
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 116
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 115
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 113
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 109
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 109
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 107
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 106
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 106
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 105
Extended coagulation profile of children with Long Covid: a prospective study 101
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 101
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 101
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 101
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 99
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 99
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 95
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 94
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 94
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 93
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 93
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 90
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 88
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 87
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 87
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 86
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 86
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 85
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 79
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 78
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 76
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 76
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 76
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 75
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 71
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 66
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 66
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 66
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 52
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 50
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 42
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 39
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 34
PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia 15
Totale 8.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.235 24 32 113 64 65 46 42 49 172 133 302 193
2025/20263.438 527 155 225 391 638 205 659 173 225 240 0 0
Totale 8.910